Advanced therapies, analysis, quality control, process optimisation.
QUATRE is a Contract Research Organisation (CRO) for biotech companies developing and commercialising Advanced Therapies. We are dedicated to the development of optimised quality control processes to guarantee the high biosafety and efficacy required by regulatory agencies for clinical application and subsequent commercialisation. It was created with the aim of developing optimised processes for the integral characterisation of Critical Quality Attribute (CQA) for the safety and efficacy of advanced therapy medicinal products (ATMPs) at an equitable cost.
DESCRIPTION
QUATRE is a Contract Research Organisation (CRO) for biotech companies developing and commercialising Advanced Therapies. We are dedicated to the development of optimised quality control processes to guarantee the high biosafety and efficacy required by regulatory agencies for clinical application and subsequent commercialisation. It was created with the aim of developing optimised processes for the integral characterisation of Critical Quality Attribute (CQA) for the safety and efficacy of advanced therapy medicinal products (ATMPs) at an equitable cost.
Keywords
Advanced therapies, analysis, quality control, process optimisation.
